Indication
Gastrointestinal Stromal Tumor (GIST)
2 clinical trials
2 products
Clinical trial
A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard TreatmentsStatus: Recruiting, Estimated PCD: 2025-01-01
Product
AtezolizumabProduct
ImatinibClinical trial
Randomized, Multicentre, Phase II Study Evaluating the Interest of Imatinib Treatment Maintenance or Interruption After at Least 10 Years of Treatment in Patients With Locally Advanced/Metastatic Gastrointestinal Stromal Tumors (GISTs)Status: Recruiting, Estimated PCD: 2025-01-01